Tagged: diabetes
11 results
Mesh Bio
Mesh Bio is a Singapore-based health deep-tech company that uses digital twin technology and predictive analytics to help clinicians detect and manage chronic diseases earlier. Its DARA platform automates health-screening report generation and risk stratification, while HealthVector Diabetes - approved as a Software as a Medical Device by Singapore's Health Sciences Authority - forecasts diabetes complications years before onset. Founded in 2018 by Andrew Wu and Arsen Batagov, the company serves more than 40 healthcare groups across Asia and has assessed over 300,000 patients.
Berry Street
Berry Street is a New York-based digital health company that connects patients with registered dietitians for insurance-covered, virtual nutrition therapy while giving those dietitians an AI-enabled 'business-in-a-box' to run independent practices. Founded in 2023 by Noah Kotlove and Jesse Rose, the platform pairs a consumer marketplace - where most clients pay $0 out of pocket - with back-office tooling that handles insurance credentialing, claims, documentation and patient communication. It works with a network of more than 1,000 dietitians and 1,250-plus insurance plans, and raised a $50 million Series B in early 2025.
Culina Health
Culina Health is a virtual nutrition care company founded in 2020 by registered dietitians Vanessa Rissetto and Tamar Samuels. It pairs patients with credentialed registered dietitians for one-on-one, insurance-covered nutrition therapy delivered via telehealth across all 50 states. The company blends evidence-based clinical care with culturally affirming, multilingual support to treat conditions ranging from diabetes and heart disease to GI disorders and eating disorders, while partnering with major insurers, Medicare, and employers to make expert nutrition care accessible.
Performance Kitchen | Food Is Medicine®
Performance Kitchen | Food Is Medicine® is an Austin, Texas company that produces chef-crafted, dietitian-approved Medically Tailored Meals designed to help manage chronic conditions such as diabetes, heart disease, and renal disease. Founded in 2011 as a healthy consumer food brand sold in more than 10,000 retail stores, the company pivoted to lead the Food Is Medicine movement, delivering ready-to-eat meals that are increasingly paid for by health insurers and delivered directly to members' homes. Led by Chairman and CEO Mark Walker, a CPA and founder of athlete-backed Dugout Ventures, Performance Kitchen operates nationwide production and distribution reaching roughly 98% of the U.S.
Simple HealthKit
Simple HealthKit is a Milpitas, California-based digital health company building end-to-end healthcare infrastructure that unifies at-home and in-clinic diagnostics, a CLIA-certified lab, telehealth, and follow-up care into a single platform. Founded in 2018 by biochemist Sheena Menezes, the company targets health equity by making testing for sexual health, respiratory illness (COVID/flu/RSV), and chronic conditions like diabetes accessible and affordable for underserved populations, selling primarily to health plans, retailers, pharmacies, employers, schools, and public health organizations.
Melior Discovery
Melior Discovery is an Exton, Pennsylvania preclinical contract research organization that specializes in in vivo pharmacology and drug repositioning. Its proprietary theraTRACE platform runs a candidate compound through a large, multiplexed panel of validated animal disease models simultaneously, systematically surfacing new therapeutic uses for existing or shelved drugs. Founded in 2005 by Andrew Reaume and Michael Saporito, the company both partners with major pharmaceutical firms and builds its own drug pipeline through spinouts, and was named CRO of the Year by Life Sciences Review in 2024.
Empo Health
Empo Health makes diabetic foot ulcer detection as easy as stepping on a bathroom scale. The Empo Footprint imaging scale captures high-resolution images of patients' feet at home and sends them to clinicians through the HIPAA-compliant Empo Remote Health Link, catching ulcers before they become amputations.
Andrew Reaume
Andrew Reaume is the co-founder, President and CEO of Melior Discovery, an Exton, Pennsylvania preclinical contract research organization built around theraTRACE, a multiplexed in vivo phenotypic screening platform that runs a single drug candidate through a battery of animal disease models at once to uncover unexpected therapeutic uses. A geneticist by training with a Wharton MBA, he conceived the idea at Pfizer, left in 2005 to build it, and has since raised over $15 million in capital, closed more than $40 million in partnering deals, and pushed a repurposed compound, MLR-1023, into Phase 2 diabetes trials.
DeLorean Artificial Intelligence
DeLorean Artificial Intelligence is a Palm Beach, Florida-based healthcare AI company that builds predictive and interventive intelligence to forecast chronic disease and recommend next-best clinical actions before a patient gets sicker. Its flagship Medical AI platform, MARTI, analyzes structured and unstructured health records to predict events like hospitalizations and disease progression - and is described as the first medical AI to be biologically validated by independent third parties. Founded in 2019 by Dr. Severence MacLaughlin, the company also applies its predictive engine to sales/CRM, life sciences, financial services and other industries.
Kaleido
Kaleido is a small, discreet, customizable insulin patch pump built by Dutch medtech company ViCentra to make living with diabetes less of a burden. Designed to look and feel like a lifestyle product rather than a clinical device, Kaleido pairs with Diabeloop's self-learning algorithm and the Dexcom CGM to enable hybrid closed-loop, app-controlled insulin delivery. With more than 3,500 users in Europe and an $85M+ Series D raised in 2025, the company is scaling manufacturing of its next-generation Kaleido 2 and preparing for entry into the United States.
Luna Diabetes
Luna Diabetes (Luna Health Inc.) is a San Diego medical device company building the first automated insulin delivery system designed for the more than 90% of insulin-requiring people who dose with an insulin pen rather than a full-time pump. Its flagship product, Luna, pairs what the company calls the world's smallest insulin patch pump with a fully closed-loop algorithm to automate micro-doses of rapid-acting insulin overnight, when most of the glucose benefit from pump therapy occurs. Founded in 2020 by diabetes-industry veterans John Sjolund, Jon Brilliant and Sean Saint, the company raised a $23.6M Series A in August 2025 and is running a pivotal clinical trial using Time in Range as its primary endpoint.